Ana Rita Nobre

About Ana Rita Nobre

Ana Rita Nobre, With an exceptional h-index of 16 and a recent h-index of 15 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Cancer metastasis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Unveiling the re-programming of choroid plexus and leptomeningeal metastasis

A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells

BSLD-06 UNVEILING THE RE-PROGRAMMING OF CHOROID PLEXUS AND LEPTOMENINGEAL METASTASIS

5-Azacytidine-and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling

A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy

Skip to the end: metastasis before tumorigenesis

ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung

An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy

Ana Rita Nobre Information

University

Position

PhD Student at

Citations(all)

1938

Citations(since 2020)

1450

Cited By

1002

hIndex(all)

16

hIndex(since 2020)

15

i10Index(all)

16

i10Index(since 2020)

16

Email

University Profile Page

Google Scholar

Ana Rita Nobre Skills & Research Interests

Cancer metastasis

Top articles of Ana Rita Nobre

Unveiling the re-programming of choroid plexus and leptomeningeal metastasis

Cancer Research

2024/3/22

Ana Rita Nobre
Ana Rita Nobre

H-Index: 11

A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells

Clinical Cancer Research

2023/12/15

BSLD-06 UNVEILING THE RE-PROGRAMMING OF CHOROID PLEXUS AND LEPTOMENINGEAL METASTASIS

Neuro-Oncology Advances

2023/8

Ana Rita Nobre
Ana Rita Nobre

H-Index: 11

5-Azacytidine-and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling

Cell reports

2023/6/27

A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy

Nature cancer

2022/1

Skip to the end: metastasis before tumorigenesis

Nature Genetics

2022/12

Ana Rita Nobre
Ana Rita Nobre

H-Index: 11

ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung

Nature Cancer

2022/10

An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy

Journal of Experimental Medicine

2021/11/23

Epigenetic reprogramming of DCCs into dormancy suppresses metastasis via restored TGFβ–SMAD4 signaling

bioRxiv

2021/8/1

PERK inhibition blocks metastasis initiation by limiting UPR-dependent survival of dormant disseminated cancer cells

bioRxiv

2021/7/30

Wei Zheng
Wei Zheng

H-Index: 95

Ana Rita Nobre
Ana Rita Nobre

H-Index: 11

Bone marrow NG2+/Nestin+ mesenchymal stem cells drive DTC dormancy via TGF-β2

Nature Cancer

2021/3

A specific agonist of the orphan nuclear receptor NR2F1 suppresses metastasis through the induction of cancer cell dormancy

bioRxiv

2021/2/2

A mesenchymal-like program of dormancy controlled by ZFP281 serves as a barrier to metastatic progression of early disseminated cancer cells

2021/1/18

On the Mechanisms of Early Dissemination, Dormancy and Metastasis

2021

NG2+/Nestin+ mesenchymal stem cells dictate DTC dormancy in the bone marrow through TGFβ2

BioRxiv

2020/10/22

The current paradigm and challenges ahead for the dormancy of disseminated tumor cells

2020/7

Ana Rita Nobre
Ana Rita Nobre

H-Index: 11

See List of Professors in Ana Rita Nobre University(Icahn School of Medicine at Mount Sinai)